GE Healthcare, a unit of US-based General Electric Company, on Wednesday launched Revolution ACT - a new, computed tomography (CT) scanner. In line with the company’s Make in India efforts, the scanner has been designed, developed and manufactured at GE’s facility in Bengaluru.
The product, 26th from the company which is made in India, will be marketed in tier-II and tier-III cities.
It will also be exported to southeast Asian countries, said John Flannery, president and chief executive officer, GE Healthcare.
GE Healthcare has already filed five global patents for its design and engineering.
“This is an affordable CT scanner developed over the past four years in Bengaluru at an estimated cost of Rs 120 crore. About 75 engineers at our R&D (research and development) centre here worked for the design and development in collaboration with 500 healthcare providers from both urban and rural settings. We are offering it at less than Rs 1 crore, which is 40 per cent less than an imported machine,” said Flannery. He added that the company would manufacture around 200 units a year and scale it up to 1,000 units a year depending on demand. Currently, there are around 3,500 CT scanners used in Indian hospitals, which is about a fifth of China’s size.
“The healthcare market in India is booming in secondary cities and we want to expand our market,” said Terri Bresenham, president and CEO, GE Healthcare South Asia. Revolution ACT consumes 40 per cent less energy and has been manufactured with about 35 per cent components sourced within India, she added.
Bresenham said GE Healthcare had recently formed a new national network - GenWorks Health Pvt Ltd - to distribute and service its equipment in tier-II to tier-IV cities in India. GenWorks has commenced operations with 150 trained professionals. To begin with, the company will focus on 450 towns to offer training and support closer to healthcare providers.
According to a company official, GE Healthcare is awaiting approval from the Atomic Energy Regulatory Board for the new scanner and sales will begin soon after getting that.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU